Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Comb Chem ; 3(6): 528-33, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11703147

RESUMO

This paper reports some of the advantages and limitations of solid-supported liquid-liquid extraction (SLE) for the rapid purification of organic compound libraries. Issues of solvent compatibility, compound compatibility, and technical methods are addressed. In addition the prospective use of calculated log P values is investigated to determine which impurities will be effectively removed by this technique. In addition SLE is shown to be complementary and in some cases superior to solid-phase extraction (SPE) methods for library purification. This is especially true when the desired products have functionality equivalent to that of the impurity to be removed.

2.
Mol Pharmacol ; 59(3): 462-9, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11179440

RESUMO

The successful synthesis of dolastatin 11, a depsipeptide originally isolated from the mollusk Dolabella auricularia, permitted us to study its effects on cells. The compound arrested cells at cytokinesis by causing a rapid and massive rearrangement of the cellular actin filament network. In a dose-and time-dependent manner, F-actin was rearranged into aggregates, and subsequently the cells displayed dramatic cytoplasmic retraction. The effects of dolastatin 11 were most similar to those of the sponge-derived depsipeptide jasplakinolide, but dolastatin 11 was about 3-fold more cytotoxic than jasplakinolide in the cells studied. Like jasplakinolide, dolastatin 11 induced the hyperassembly of purified actin into filaments of apparently normal morphology. Dolastatin 11 was qualitatively more active than jasplakinolide and, in a quantitative assay we developed, dolastatin 11 was twice as active as jasplakinolide and 4-fold more active than phalloidin. However, in contrast to jasplakinolide and phalloidin, dolastatin 11 did not inhibit the binding of a fluorescent phalloidin derivative to actin polymer nor was it able to displace the phalloidin derivative from polymer. Thus, despite its structural similarity to other agents that induce actin assembly (all are peptides or depsipeptides), dolastatin 11 may interact with actin polymers at a distinct drug binding site.


Assuntos
Citoesqueleto de Actina/efeitos dos fármacos , Actinas/efeitos dos fármacos , Antineoplásicos/farmacologia , Proteínas de Bactérias , Depsipeptídeos , Oligopeptídeos/farmacologia , Peptídeos Cíclicos/farmacologia , Actinas/imunologia , Actinas/metabolismo , Actinas/ultraestrutura , Animais , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Dipodomys , Corantes Fluorescentes/metabolismo , Isotiocianatos/metabolismo , Oligopeptídeos/síntese química , Oligopeptídeos/química , Peptídeos/síntese química , Peptídeos/química , Peptídeos/farmacologia , Peptídeos Cíclicos/síntese química , Peptídeos Cíclicos/química , Faloidina/farmacologia
3.
Fitoterapia ; 71(2): 195-8, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10727820

RESUMO

A phytochemical investigation of the chloroform leaf extract of Alchornea latifolia has been undertaken. Along with the triterpenoids taraxerone, friedelin, epifriedelinol, and taraxerol, the plant also contains seco-3,4-friedelin (dihydroputranjivic acid) (1) and seco-3,4-taraxerone (2). These A-ring-opened triterpenoids show in vitro cytotoxic activity against Hep-G2 and A-431 human cancer cell lines and are potent inhibitors of topoisomerase II.


Assuntos
Euphorbiaceae , Ácido Oleanólico/análogos & derivados , Ácido Oleanólico/farmacologia , Plantas Medicinais , Triterpenos/farmacologia , Humanos , Medicinas Tradicionais Africanas , Testes de Sensibilidade Microbiana , Ácido Oleanólico/química , Fitoterapia , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Folhas de Planta , Staphylococcus aureus/efeitos dos fármacos , Streptococcus pneumoniae/efeitos dos fármacos , Triterpenos/química , Células Tumorais Cultivadas/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...